Margaret Cupit-Link

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Chemotherapy Induced

Top Venues

The New England journal of medicine

Research square

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Margaret Cupit-Link, Kohei Hagiwara, Matthew Nagy, Selene C Koo, Brent A Orr, Eytan Ruppin, John Easton, Jinghui Zhang, Sara M Federico
Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma. The New England journal of medicine 391 (7) (2024)
Margaret Cupit-Link, Kohei Hagiwara, Matthew Nagy, Selene C Koo, Brent A Orr, Eytan Ruppin, John Easton, Jinghui Zhang, Sara M Federico
Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma. The New England journal of medicine 391 (7) (2024)
Margaret Cupit-Link
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Margaret Cupit-Link, Kohei Hagiwara, Matthew Nagy, Selene C Koo, Brent A Orr, Eytan Ruppin, John Easton, Jinghui Zhang, Sara M Federico
Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma. The New England journal of medicine 391 (7) (2024)
Margaret Cupit-Link, Sara M Federico
Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction. Cancers 15 (18) (2023)
Sara Federico, Margaret Cupit-Link, Kohei Hagiwara, Jinghui Zhang
Clinical Response to a PARP Inhibitor and Chemotherapy in a Child with BARD1-Mutated Refractory Neuroblastoma: A Case Report. Research square (2023)